The mission of ACGT is to support the extraordinary potential offered by cell and gene-based therapies to accelerate effective and safe treatment of all types of cancer.
ACGT is committed to building alliances between philanthropic individuals and organizations, and medical and academic institutions, to promote gene therapy research to combat cancer.
To this end, ACGT will identify, fund and monitor innovative research that meets a rigorous set of scientific standards, and has the potential, in the foreseeable future, to treat cancers of all types.
Through this endeavor, ACGT will educate the public about the potential for cancer gene therapy and facilitate greater collaborations among the scientific community to foster the best possible research and ultimately the best treatment.
Alliance for Cancer Gene Therapy, Inc. [ACGT] is a 501 [c]  non-profit public charity founded in 2001 by Barbara and Edward Netter to facilitate funding for high-potential research into cell and gene therapies, in the hopes of realizing an effective alternative to the treatment and management of cancer.